Home>News Center>World
         
 

Resistance to Tamiflu seen in Vietnam bird-flu case
By Marilyn Chase, Santanu Choudhury (The Wall Street Journal)
Updated: 2005-10-17 10:32

An Indian drug maker said it soon will produce a generic version of the antiviral considered to be the best treatment for bird flu, and scientists revealed worrying new details about a case in which the virus proved resistant to the drug.

Researchers said that the bird-flu virus found in a Vietnamese teenager in February was resistant to the drug Tamiflu. The girl later recovered, but the case, to be reported in the Oct. 20 issue of the journal Nature, heightens concern about the Roche Holding AG drug, currently the centerpiece of global and national drug stockpiles against a possible pandemic of H5N1 avian influenza.

The 14-year-old girl hadn't had direct contact with sick poultry but had cared for her 21-year-old brother while he was ill with a documented case of avian flu. Such circumstances "raise the possibility that the virus would have been transmitted from brother to sister," the researchers wrote. A handful of other cases have raised the same possibility, but sustained human-to-human transmission hasn't been proved.

Yoshihiro Kawaoka, a professor of virology at the University of Tokyo and senior author of the Nature study, said the discovery wasn't a surprise, given his earlier findings that 18% of Japanese children developed resistance after being treated with Tamiflu for normal, seasonal flu.

"The message is don't get panicked," said Dr. Kawaoka. "The vast majority of H5N1 viruses out there are still sensitive to oseltamivir," the generic name for Tamiflu, he said in an interview. "We should do what we planned, which is to stockpile oseltamavir, and perhaps we should consider zanamavir too," he added, referring to Relenza, the inhaled flu drug from Britain's GlaxoSmithKline PLC.

Amid calls for greatly increasing supplies of Tamiflu, meanwhile, Indian generic powerhouse Cipla Ltd. said Friday that it has synthesized the drug and could begin production in January or February.

The company said its generic oseltamivir won't be commercially launched, but only sold in countries that desperately need it -- not in Europe or North America.

Switzerland's Roche said in a written statement that it hasn't been approached by Cipla or any other company asking for the right to produce Tamiflu. Asked whether it would consider legal action against Cipla, Roche said, "We are not aware of any [patent] infringements and thus do not speculate on that."



USS Park Royal crew await for Rice
Coffin of Milosevic flew to Belgrade
Kidnapping spree in Gaza Strip
 
  Today's Top News     Top World News
 

Australia, US, Japan praise China for Asia engagement

 

   
 

Banker: China doing its best on flexible yuan

 

   
 

Hopes high for oil pipeline deal

 

   
 

Possibilities of bird flu outbreaks reduced

 

   
 

Milosevic buried after emotional farewell

 

   
 

China considers trade contracts in India

 

   
  Journalist's alleged killers held in Iraq
   
  No poisons found in Milosevic's body
   
  US, Britain, France upbeat on Iran agreement
   
  Fatah officials call for Abbas to resign
   
  Sectarian violence increases in Iraq
   
  US support for troops in Iraq hits new low
   
 
  Go to Another Section  
 
 
  Story Tools  
   
Manufacturers, Exporters, Wholesalers - Global trade starts here.
Advertisement
         
主站蜘蛛池模板: 免费人成视频在线观看不卡| 韩国免费特一级毛片| 精品久久久无码中文字幕| 在线天堂中文官网| 亚洲av中文无码乱人伦在线视色| 18videosex性欧美69免费播放| 日本乱人伦中文在线播放| 免费日本黄色片| 亚洲欧美日韩国产一区图片 | 欧美大bbbxxx视频| 性xxxx18免费观看视频| 亚洲国产一二三| 精品国产污污免费网站| 国产欧美日韩一区| 一区二区三区在线看| 欧洲成人爽视频在线观看| 免费观看黄色的网站| 91香蕉视频导航| videosgratis侏儒孕交| 男人j桶进女人p无遮挡免费 | 鬼作动漫1~6集在线观看| 在线资源天堂www| 久久久久99精品成人片试看| 欧美日韩不卡合集视频| 又黄又爽又猛大片录像| 久久五月天婷婷| 处处吻动漫免费观看全集| 一个人看的视频www在线| 日本黄色影院在线观看| 今天免费中文字幕视频| 视频二区三区国产情侣在线| 国产精品国产三级国产AV′| а天堂中文最新一区二区三区| 我要看免费的毛片| 九九免费精品视频在这里| 爱情岛永久地址www成人| 国产一区二区三区手机在线观看| 香蕉久久综合精品首页| 女bbbbxxxx另类亚洲| 久久一本一区二区三区| 樱花草在线播放免费|